SEC Form 4 · accession 0001179110-18-001372

ABBOTT LABORATORIES · ABT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Robert B Ford

Officer — Executive Vice President

Period of report

Jan 30, 2018

Accepted (ET)

Feb 1, 2018 · 5:47 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000001800

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common shares without par value	Jan 30, 2018	M	4,467	$26.1879	A	56,633	D
Common shares without par value	Jan 30, 2018	M	10,400	$22.3919	A	67,033	D
Common shares without par value	Jan 30, 2018	M	19,600	$27.0336	A	86,633	D
Common shares without par value	Jan 30, 2018	M	49,000	$34.94	A	135,633	D
Common shares without par value	Jan 30, 2018	S	200	$62.81	D	135,433	D
Common shares without par value	Jan 30, 2018	S	300	$62.82	D	135,133	D
Common shares without par value	Jan 30, 2018	S	100	$62.825	D	135,033	D
Common shares without par value	Jan 30, 2018	S	527	$62.83	D	134,506	D
Common shares without par value	Jan 30, 2018	S	100	$62.84	D	134,406	D
Common shares without par value	Jan 30, 2018	S	200	$62.845	D	134,206	D
Common shares without par value	Jan 30, 2018	S	100	$62.85	D	134,106	D
Common shares without par value	Jan 30, 2018	S	100	$62.86	D	134,006	D
Common shares without par value	Jan 30, 2018	S	400	$62.88	D	133,606	D
Common shares without par value	Jan 30, 2018	S	200	$62.89	D	133,406	D
Common shares without par value	Jan 30, 2018	S	200	$62.8975	D	133,206	D
Common shares without par value	Jan 30, 2018	S	100	$62.90	D	133,106	D
Common shares without par value	Jan 30, 2018	S	200	$62.91	D	132,906	D
Common shares without par value	Jan 30, 2018	S	200	$62.93	D	132,706	D
Common shares without par value	Jan 30, 2018	S	1,100	$62.95	D	131,606	D
Common shares without par value	Jan 30, 2018	S	200	$62.955	D	131,406	D
Common shares without par value	Jan 30, 2018	S	2,700	$62.96	D	128,706	D
Common shares without par value	Jan 30, 2018	S	200	$62.965	D	128,506	D
Common shares without par value	Jan 30, 2018	S	2,000	$62.97	D	126,506	D
Common shares without par value	Jan 30, 2018	S	400	$62.975	D	126,106	D
Common shares without par value	Jan 30, 2018	S	1,000	$62.98	D	125,106	D
Common shares without par value	Jan 30, 2018	S	1,346	$62.985	D	123,760	D
Common shares without par value	Jan 30, 2018	S	100	$62.9875	D	123,660	D
Common shares without par value	Jan 30, 2018	S	3,600	$62.99	D	120,060	D
Common shares without par value	Jan 30, 2018	S	5,303	$62.995	D	114,757	D
Common shares without par value	Jan 30, 2018	S	21,789	$63.00	D	92,968	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Option (right to buy)^F1	$26.1879	Jan 30, 2018	M	4,467	D	Feb 19, 2013	Feb 18, 2020	Common shares	4,467	D
Option (right to buy)^F1	$22.3919	Jan 30, 2018	M	10,400	D	Feb 18, 2014	Feb 17, 2021	Common shares	10,400	D
Option (right to buy)^F1	$27.0336	Jan 30, 2018	M	19,600	D	Feb 17, 2015	Feb 16, 2022	Common shares	19,600	D
Option (right to buy)^F1	$34.94	Jan 30, 2018	M	49,000	D	Feb 15, 2016	Feb 14, 2023	Common shares	49,000	D

Explanation of responses

F1Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Remarks

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).Form 1 of 2.